Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study.

Tytuł :
Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study.
Autorzy :
Dolengevich-Segal H; Psychiatry Service, Henares University Hospital, Madrid, Spain.; Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.
Gonzalez-Baeza A; HIV Unit, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Valencia J; Harm Reduction Unit, SERMAS, Madrid, Spain.
Valencia-Ortega E; HIV Unit, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Cabello A; Infectious Diseases and HIV Unit, Fundación Jimenez Díaz, Madrid, Spain.
Tellez-Molina MJ; HIV Unit, Clínico San Carlos University Hospital, Madrid, Spain.
Perez-Elias MJ; Infectious Diseases, Ramón y Cajal University Hospital, Madrid, Spain.
Serrano R; Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.; HIV Unit, Henares University Hospital, Madrid, Spain.
Perez-Latorre L; HIV Unit, Gregorio Marañón University Hospital, Madrid, Spain.
Martin-Carbonero L; HIV Unit, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Arponen S; Internal Medicine Service, Torrejon Hospital, Madrid, Spain.
Sanz-Moreno J; Internal Medicine, Príncipe de Asturias Hospital, Alcala de Henares, Spain.
De la Fuente S; Internal Medicine Service, Puerta de Hierro Hospital, Madrid, Spain.
Bisbal O; HIV Unit, 12 de Octubre University Hospital, Madrid, Spain.
Santos I; Infectious Diseases Unit, La Princesa University Hospital, Madrid, Spain.
Casado JL; Infectious Diseases, Ramón y Cajal University Hospital, Madrid, Spain.
Troya J; Internal Medicine Service, Infanta Leonor Hospital, Madrid, Spain.
Cervero-Jimenez M; Internal Medicine Service, Severo Ochoa Hospital, Madrid, Spain.
Nistal S; Internal Medicine Service, Mostoles University Hospital, Madrid, Spain.
Cuevas G; Internal Medicine Service, Infanta Leonor Hospital, Madrid, Spain.
Correas-Lauffer J; Psychiatry Service, Henares University Hospital, Madrid, Spain.; Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.
Torrens M; Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain.
Ryan P; Internal Medicine Service, Infanta Leonor Hospital, Madrid, Spain.; School of Medicine, Complutense University, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Pokaż więcej
Corporate Authors :
U-SEX GESIDA 9416 Study
Źródło :
PloS one [PLoS One] 2019 Dec 04; Vol. 14 (12), pp. e0220272. Date of Electronic Publication: 2019 Dec 04 (Print Publication: 2019).
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms :
Psychopathology*
HIV/*drug effects
HIV Infections/*pathology
HIV Infections/*psychology
Homosexuality, Male/*statistics & numerical data
Sexual Behavior/*psychology
Substance Abuse, Intravenous/*complications
Adult ; Cross-Sectional Studies ; HIV Infections/etiology ; Humans ; Male ; Risk-Taking
References :
J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686)
HIV Med. 2018 Apr;19(4):261-270. (PMID: 29368440)
Case Rep Psychiatry. 2016;2016:8379562. (PMID: 27247820)
Int J STD AIDS. 2017 Jan;28(1):91-93. (PMID: 27542697)
Int J Drug Policy. 2018 May;55:222-230. (PMID: 29429864)
PLoS One. 2014 Jan 23;9(1):e86603. (PMID: 24466166)
Int J Drug Policy. 2016 Dec;38:4-12. (PMID: 27788450)
Drug Alcohol Rev. 2008 May;27(3):253-62. (PMID: 18368606)
Hum Psychopharmacol. 2015 Jul;30(4):233-43. (PMID: 26216556)
Int J Drug Policy. 2015 Dec;26(12):1171-6. (PMID: 26298332)
Adicciones. 2017 Jun 28;29(3):207-209. (PMID: 28492961)
Int J Drug Policy. 2012 May;23(3):188-97. (PMID: 22342322)
AIDS Patient Care STDS. 2012 Jan;26(1):36-52. (PMID: 22070609)
Harm Reduct J. 2016 Dec 9;13(1):36. (PMID: 27938393)
Int J Drug Policy. 2017 Nov;49:24-25. (PMID: 28873358)
AIDS Patient Care STDS. 2018 Mar;32(3):112-118. (PMID: 29620925)
Lancet. 2013 Jan 12;381(9861):101-2. (PMID: 23320280)
Life Sci. 2014 Feb 27;97(1):2-8. (PMID: 23911668)
CNS Neurosci Ther. 2013 Jun;19(6):454-60. (PMID: 23421859)
Int J Drug Policy. 2016 Mar;29:66-72. (PMID: 26851066)
J Neuroimmune Pharmacol. 2012 Mar;7(1):113-39. (PMID: 21728034)
BMJ. 2015 Nov 03;351:h5790. (PMID: 26537832)
Hum Psychopharmacol. 2013 Jul;28(4):308-16. (PMID: 23881878)
Lancet HIV. 2014 Oct;1(1):e22-31. (PMID: 26423813)
Entry Date(s) :
Date Created: 20191205 Date Completed: 20200324 Latest Revision: 20200324
Update Code :
20201023
PubMed Central ID :
PMC6892548
DOI :
10.1371/journal.pone.0220272
PMID :
31800575
Czasopismo naukowe
Objectives: Sexualized intravenous drug use, also known as slamsex, seems to be increasing among HIV-positive men who have sex with men (MSM). Physical and psychopathological symptoms have previously been reported in this population, although research on the subject of slamsex is scarce. The objectives of our study were to describe the psychopathological background of a sample of HIV-positive MSM who engaged in slamsex during the previous year and to compare physical, psychopathological, and drug-related symptoms between these participants and those who engaged in non-injecting sexualized drug use.
Design and Methods: Participants (HIV-positive MSM) were recruited from the U-Sex study in 22 HIV clinics in Madrid during 2016-17. All participants completed an anonymous cross-sectional online survey on sexual behavior and recreational drug use. When participants met the inclusion criteria, physicians offered them the opportunity to participate and gave them a card with a unique code and a link to access the online survey. The present analysis is based on HIV-positive MSM who had engaged in slamsex and non-injecting sexualized drug use.
Results: The survey sample comprised 742 participants. Of all the participants who completed the survey, 216 (29.1%) had engaged in chemsex, and of these, 34 (15.7%) had engaged in slamsex. Participants who engaged in slamsex were more likely to have current psychopathology (depression, anxiety, and drug-related disorders) than participants who engaged in non-injecting sexualized drug use. In addition, participants who engaged in slamsex more frequently reported high-risk sexual behaviors and polydrug use and were more often diagnosed with sexually transmitted infections (STIs) and hepatitis C than those who did not inject drugs. Compared with participants who did not inject drugs, participants who engaged in slamsex experienced more severe drug-related symptoms (withdrawal and dependence), symptoms of severe intoxication (loss of consciousness), and severe psychopathological symptoms during or after slamsex (eg, paranoid thoughts and suicidal behaviors).
Conclusion: Slamsex is closely associated with current psychiatric disorders and severe drug-related and psychiatric symptoms.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies